| Literature DB >> 32083138 |
Mihaela L Vică1, Horea V Matei1,2, Cosmina I Bondor3, Gheorghe Z Nicula1, Costel V Siserman2,4, Luminița Loga5, Lucia Dican5,6.
Abstract
Transylvania is a historical region in the northwestern part of Romanian with a rather heterogeneous population. Our study is the first to determine human leukocyte antigen (HLA) profiles in a large population sample from this region and to compare them with other European population groups. HLA genes were examined in 2,794 individuals using the Single Specific Primer-Polymerase Chain Reaction (SSP-PCR) and Polymerase Chain Reaction Sequence-Specific Oligonucleotide (PCR-SSO) methods. All samples were tested for the HLA-A locus, 2,773 for HLA-B, 1,847 for HLA-C, and 2,719 for HLA-DRB1 loci. HLA gene frequency data from several European population groups (as presented in studies involving more than 1,000 individuals) served as reference in comparison with the local sample. The distribution of HLA genes in the studied population group was heterogeneous, as the Hardy-Weinberg equilibrium was statistically significant (P value < 0.01). The most common genes found in our sample group were A∗02 (0.27%), B∗35 (0.14%), C∗07 (0.25%), and DRB1∗11 (0.19%). The most common haplotype was A∗01~B∗08~C∗07~DRB1∗03 (1.26% in 1,770 individuals with complete data). This analysis confirmed the known heterogeneity of the Transylvanian population. The study indicates that the European population groups located in close vicinity (those from Serbia, Hungary, Wallachia, and Croatia) are genetically closest to the Transylvanian population.Entities:
Mesh:
Substances:
Year: 2019 PMID: 32083138 PMCID: PMC7012258 DOI: 10.1155/2019/1342762
Source DB: PubMed Journal: J Immunol Res ISSN: 2314-7156 Impact factor: 4.818
Figure 1Resources which provided the frequencies of the HLA-A, HLA-B, HLA-C, and HLA-DRB1 genes in several European population groups.
| Population group | Number of individuals sampled for the HLA-A, HLA-B, HLA-C, and HLA-DRB1 genes | Source | |
|---|---|---|---|
|
| Published references | ||
| Wallachia | A = 5,252, B = 4,914, DRB1 = 5,072 | — | Constantinescu et al. [ |
| Hungary | A = 1,644; B = 1,653 | — | Inotai et al. [ |
| Greece | A = 10,947, B = 11,061, | Iniotaki and Siorenta, 2012, Bone Marrow Registry | — |
| Serbia | A, B, DRB1 = 1,992 | Andric et al., 2010, Bone Marrow Registry | Andric et al. [ |
| Croatia | A, B, DRB1 = 4,000 | Grubic et al., 2011, Bone Marrow Registry | Grubic et al. [ |
| Czech Republic | A, B, DRB1 = 5,099, C = 4,669 | Czech National Marrow Donors Registry, 2014 | — |
| Slovakia | A = 3,693, B = 3,944, DRB1 = 3,744 | Kušíková, 2013, Bone Marrow Registry | — |
| Poland | A, B, C, DRB1 = 2,907 | Nowak et al., 2013, Bone Marrow Registry | — |
| Russia | A, B, C, DRB1 = 2,650 | Lebedeva, 2009, Moscow Stem Cell Bank | — |
| Germany | A, B, DRB1 = 11,407 | Seidl et al., 2005, Bone Marrow Registry | — |
| France | A, B, C, DRB1 = 6,094 | Alizadeh et al., 2006, Bone Marrow Registry | — |
| Italy | A, B = 159,311, DRB1 = 40,071 | Rendine et al., 1998, Bone Marrow Registry | Rendine et al. [ |
| Portugal | A, B, DRB1 = 17,420 | Ligeiro, 2009, Bone Marrow Registry | — |
| Spain | DRB1 = 1,818 | Garcia-Sanz, 2007, Bone Marrow Registry | — |
The HLA-A (n = 2,794), HLA-B (n = 2,773), HLA-C (n = 1,847), and HLA-DRB1 (n = 2,719) gene frequencies in the Transylvanian sample.
| Gene HLA-A | Frequency (%) | Gene HLA-B | Frequency (%) | Gene HLA-C | Frequency (%) | Gene HLA-DRB1 | Frequency (%) |
|---|---|---|---|---|---|---|---|
| A∗01 | 14.2 | B∗07 | 5.7 | C∗01 | 5.4 | DRB1∗01 | 9.8 |
| A∗02 | 26.9 | B∗08 | 8.6 | C∗02 | 7.2 | DRB1∗03 | 11.4 |
| A∗03 | 11.1 | B∗13 | 3.8 | C∗03 | 7.7 | DRB1∗04 | 8.8 |
| A∗11 | 7.3 | B∗14 | 2.5 | C∗04 | 15.1 | DRB1∗07 | 10.6 |
| A∗23 | 2.7 | B∗15 | 3.9 | C∗05 | 3.9 | DRB1∗08 | 2.5 |
| A∗24 | 11.8 | B∗18 | 11.2 | C∗06 | 8.9 | DRB1∗09 | 0.2 |
| A∗25 | 3.3 | B∗27 | 5 | C∗07 | 24.8 | DRB1∗10 | 1.1 |
| A∗26 | 5.1 | B∗35 | 13.9 | C∗08 | 2.7 | DRB1∗11 | 19 |
| A∗29 | 1.6 | B∗37 | 1 | C∗12 | 13.9 | DRB1∗12 | 1.7 |
| A∗30 | 2.6 | B∗38 | 4.3 | C∗14 | 2.4 | DRB1∗13 | 11.4 |
| A∗31 | 2.3 | B∗39 | 2.3 | C∗15 | 5.2 | DRB1∗14 | 4.3 |
| A∗32 | 4.5 | B∗40 | 5.1 | C∗16 | 1.7 | DRB1∗15 | 8.8 |
| A∗33 | 2.1 | B∗41 | 1.6 | C∗17 | 1.2 | DRB1∗16 | 10.3 |
| A∗34 | 0.04 | B∗42 | 0.02 | C∗18 | 0 | — | — |
| A∗36 | 0 | B∗44 | 10 | — | — | — | — |
| A∗43 | 0 | B∗45 | 0.3 | — | — | — | — |
| A∗66 | 0.9 | B∗46 | 0.1 | — | — | — | — |
| A∗68 | 3.1 | B∗47 | 0.6 | — | — | — | — |
| A∗69 | 0.2 | B∗48 | 0.3 | — | — | — | — |
| A∗74 | 0.2 | B∗49 | 1.7 | — | — | — | — |
| A∗80 | 0 | B∗50 | 1 | — | — | — | — |
| — | — | B∗51 | 8.9 | — | — | — | — |
| — | — | B∗52 | 2.2 | — | — | — | — |
| — | — | B∗53 | 0.2 | — | — | — | — |
| — | — | B∗54 | 0.02 | — | — | — | — |
| — | — | B∗55 | 1.8 | — | — | — | — |
| — | — | B∗56 | 0.8 | — | — | — | — |
| — | — | B∗57 | 2 | — | — | — | — |
| — | — | B∗58 | 1.3 | — | — | — | — |
| — | — | B∗59 | 0 | — | — | — | — |
| — | — | B∗67 | 0 | — | — | — | — |
| — | — | B∗73 | 0.04 | — | — | — | — |
| — | — | B∗78 | 0 | — | — | — | — |
| — | — | B∗81 | 0 | — | — | — | — |
| — | — | B∗82 | 0 | — | — | — | — |
| — | — | B∗83 | 0 | — | — | — | — |
n: number of analyzed subjects; P: value of the Hardy-Weinberg exact equilibrium test for gene frequencies at each locus.
The most frequent 50 HLA-A~B~DRB1 haplotypes from the 2,708 analyzed individuals presented in descending order of their frequency.
| Rank | HLA-A~B~DRB1 haplotype | Haplotype frequency (%) | Rank | HLA-A~B~DRB1 haplotype | Haplotype frequency (%) |
|---|---|---|---|---|---|
| 1 | A∗01~B∗08~DRB1∗03 | 1.70 | 26 | A∗02~B∗35~DRB1∗13 | 0.33 |
| 2 | A∗02~B∗18~DRB1∗11 | 1.45 | 27 | A∗02~B∗51~DRB1∗13 | 0.33 |
| 3 | A∗02~B∗35~DRB1∗11 | 0.68 | 28 | A∗03~B∗35~DRB1∗11 | 0.32 |
| 4 | A∗02~B∗08~DRB1∗03 | 0.66 | 29 | A∗02~B∗27~DRB1∗01 | 0.32 |
| 5 | A∗02~B∗44~DRB1∗11 | 0.66 | 30 | A∗01~B∗18~DRB1∗11 | 0.31 |
| 6 | A∗24~B∗35~DRB1∗11 | 0.60 | 31 | A∗02~B∗07~DRB1∗11 | 0.31 |
| 7 | A∗03~B∗35~DRB1∗01 | 0.55 | 32 | A∗11~B∗18~DRB1∗11 | 0.31 |
| 8 | A∗24~B∗18~DRB1∗11 | 0.55 | 33 | A∗02~B∗38~DRB1∗13 | 0.30 |
| 9 | A∗02~B∗51~DRB1∗11 | 0.54 | 34 | A∗25~B∗18~DRB1∗15 | 0.29 |
| 10 | A∗02~B∗51~DRB1∗16 | 0.53 | 35 | A∗01~B∗35~DRB1∗11 | 0.29 |
| 11 | A∗02~B∗44~DRB1∗16 | 0.53 | 36 | A∗02~B∗18~DRB1∗07 | 0.29 |
| 12 | A∗02~B∗35~DRB1∗01 | 0.49 | 37 | A∗23~B∗44~DRB1∗07 | 0.29 |
| 13 | A∗11~B∗35~DRB1∗01 | 0.44 | 38 | A∗02~B∗35~DRB1∗16 | 0.28 |
| 14 | A∗02~B∗18~DRB1∗16 | 0.43 | 39 | A∗02~B∗40~DRB1∗13 | 0.28 |
| 15 | A∗02~B∗13~DRB1∗07 | 0.42 | 40 | A∗24~B∗44~DRB1∗11 | 0.27 |
| 16 | A∗03~B∗18~DRB1∗11 | 0.42 | 41 | A∗02~B∗18~DRB1∗15 | 0.26 |
| 17 | A∗03~B∗07~DRB1∗15 | 0.42 | 42 | A∗02~B∗44~DRB1∗01 | 0.26 |
| 18 | A∗24~B∗08~DRB1∗03 | 0.42 | 43 | A∗03~B∗08~DRB1∗03 | 0.26 |
| 19 | A∗01~B∗08~DRB1∗11 | 0.40 | 44 | A∗03~B∗51~DRB1∗11 | 0.26 |
| 20 | A∗02~B∗44~DRB1∗07 | 0.39 | 45 | A∗02~B∗15~DRB1∗04 | 0.26 |
| 21 | A∗02~B∗44~DRB1∗04 | 0.37 | 46 | A∗32~B∗35~DRB1∗11 | 0.26 |
| 22 | A∗02~B∗44~DRB1∗13 | 0.36 | 47 | A∗01~B∗08~DRB1∗13 | 0.25 |
| 23 | A∗02~B∗07~DRB1∗15 | 0.35 | 48 | A∗01~B∗08~DRB1∗16 | 0.25 |
| 24 | A∗02~B∗27~DRB1∗16 | 0.34 | 49 | A∗02~B∗40~DRB1∗11 | 0.25 |
| 25 | A∗11~B∗35~DRB1∗11 | 0.33 | 50 | A∗01~B∗40~DRB1∗14 | 0.25 |
Comparison of HLA-A gene frequencies in the Transylvanian (n = 2,794) vs. other European population groups.
| Gene | Greece | Serbia | Croatia | Czech Republic | Slovakia | Poland | Russia | Germany | France | Italy | Portugal | Hungary | Wallachia |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A∗01 | X | X | X | X | X | X | X | X | X | ||||
| A∗02 | X | X | X | X | X | X | |||||||
| A∗03 | X | X | X | X | X | X | X | ||||||
| A∗11 | X | X | X | X | X | X | X | X | X | ||||
| A∗23 | X | X | X | X | X | X | X | X | X | X | X | X | |
| A∗24 | X | X | X | X | X | X | |||||||
| A∗25 | X | X | X | X | X | ||||||||
| A∗26 | X | X | X | X | X | X | X | X | X | X | |||
| A∗29 | X | X | X | X | X | X | X | ||||||
| A∗30 | X | X | X | X | X | X | X | X | X | X | |||
| A∗31 | X | X | X | X | X | X | X | X | X | X | X | X | X |
| A∗32 | X | X | X | X | X | X | X | X | X | ||||
| A∗33 | X | X | X | X | X | X | X | ||||||
| A∗34 | X | X | X | X | X | X | X | X | X | X | X | X | |
| A∗66 | X | X | X | X | X | X | X | ||||||
| A∗68 | X | X | X | X | X | X | X | X | X | X | X | ||
| A∗69 | X | X | X | X | X | X | X | X | X | X | X | ||
| A∗74 | X | X | X | X | X | X | X | X | |||||
|
| 10,947 | 1,992 | 4,000 | 5,099 | 3,693 | 2,907 | 2,650 | 11,407 | 6,094 | 159,311 | 17,420 | 1,644 | 5252 |
n: number of analyzed subjects; X: not statistically significant P value. Resources presented in Table 1 provided the gene frequency references.
Comparison of HLA-B gene frequencies in the Transylvanian (n = 2,773) vs. other European population groups.
| Gene | Greece | Serbia | Croatia | Czech Republic | Slovakia | Poland | Russia | Germany | France | Italy | Portugal | Hungary | Wallachia |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B∗07 | X | X | X | X | |||||||||
| B∗08 | X | X | X | X | X | X | |||||||
| B∗13 | X | X | X | X | X | X | X | X | |||||
| B∗14 | X | X | X | X | X | X | X | X | X | X | |||
| B∗15 | X | X | X | X | X | ||||||||
| B∗18 | X | X | X | X | X | ||||||||
| B∗27 | X | X | X | X | X | X | X | X | X | X | |||
| B∗35 | X | X | X | X | |||||||||
| B∗37 | X | X | X | X | X | X | X | X | X | X | X | X | X |
| B∗38 | X | X | X | X | X | X | X | ||||||
| B∗39 | X | X | X | X | X | X | X | X | X | X | X | X | |
| B∗40 | X | X | X | X | X | X | X | X | |||||
| B∗41 | X | X | X | X | X | X | X | X | X | ||||
| B∗42 | X | X | X | X | X | X | X | X | X | X | X | X | X |
| B∗44 | X | X | X | X | X | X | X | X | |||||
| B∗45 | X | X | X | X | X | X | X | X | X | X | X | X | |
| B∗46 | X | X | X | X | X | X | X | X | X | X | |||
| B∗47 | X | X | X | X | X | X | X | X | X | X | X | X | |
| B∗48 | X | X | X | X | X | X | X | X | X | ||||
| B∗49 | X | X | X | X | X | X | X | X | X | ||||
| B∗50 | X | X | X | X | X | X | X | X | X | ||||
| B∗51 | X | X | X | ||||||||||
| B∗52 | X | X | X | X | X | X | |||||||
| B∗53 | X | X | X | X | X | X | X | ||||||
| B∗54 | X | X | X | X | X | X | X | X | X | X | X | X | X |
| B∗55 | X | X | X | X | X | X | X | ||||||
| B∗56 | X | X | X | X | X | X | X | X | X | X | X | ||
| B∗57 | X | X | X | X | X | X | X | ||||||
| B∗58 | X | X | X | X | X | X | X | X | X | ||||
| B∗73 | X | X | X | X | X | X | X | X | X | X | X | ||
|
| 11,061 | 1,992 | 4,000 | 5,099 | 3,944 | 2,907 | 2,650 | 11,407 | 6,094 | 159,311 | 17,420 | 1,653 | 4,914 |
n: number of analyzed subjects; X: not statistically significant P value. Resources presented in Table 1 provided the gene frequency references.
Comparison of HLA-C gene frequencies in the Transylvanian (n = 1,847) vs. other European population groups.
| Gene | Czech Republic | Poland | Russia | France |
|---|---|---|---|---|
| C∗01 | X | X | ||
| C∗02 | X | X | ||
| C∗03 | X | |||
| C∗04 | ||||
| C∗05 | X | X | X | |
| C∗06 | ||||
| C∗07 | X | X | ||
| C∗08 | X | X | X | |
| C∗12 | X | X | ||
| C∗14 | X | X | ||
| C∗15 | ||||
| C∗16 | X | X | ||
| C∗17 | X | X | ||
|
| 4,669 | 2,907 | 2,650 | 6,094 |
n: number of analyzed subjects; X: not statistically significant P value. Resources presented in Table 1 provided the gene frequency references.
Comparison of HLA-DRB1 gene frequencies in the Transylvanian (n = 2,719) vs. other European population groups.
| Gene | Greece | Serbia | Croatia | Czech Republic | Slovakia | Poland | Russia | Germany | France | Italy | Portugal | Spain | Hungary | Wallachia |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DRB1∗01 | X | X | X | X | X | X | X | X | X | X | X | X | ||
| DRB1∗03 | X | X | X | X | X | X | X | X | X | X | X | X | ||
| DRB1∗04 | X | X | X | X | X | X | ||||||||
| DRB1∗07 | X | X | ||||||||||||
| DRB1∗08 | X | X | X | X | X | |||||||||
| DRB1∗09 | X | X | X | X | ||||||||||
| DRB1∗10 | X | X | X | X | X | X | X | X | X | X | X | X | X | |
| DRB1∗11 | X | X | ||||||||||||
| DRB1∗12 | X | X | X | X | X | X | X | X | X | X | X | |||
| DRB1∗13 | X | X | X | X | X | |||||||||
| DRB1∗14 | X | X | X | X | X | |||||||||
| DRB1∗15 | X | X | X | X | X | X | ||||||||
| DRB1∗16 | X | X | X | |||||||||||
|
| 9,081 | 1,992 | 4,000 | 5,099 | 3,744 | 2,907 | 2,650 | 11,407 | 6,094 | 40,071 | 17,420 | 1,818 | 2,402 | 5,072 |
n: number of analyzed subjects; X: not statistically significant P value. Resources presented in Table 1 provided the gene frequency references.
Figure 2